Introduction: Farmers’ cognizance regarding pesticide use and overuse is limited and their practices for handling of pesticides is unsatisfactory. However, their perception concerning risks and safety of pesticides play a very important role in safe spraying and indirectly protect them from adverse health hazards. Objective: To assess the cognizance about use and risks of overuse of pesticides and evaluate practices for the storage, preparation, and disposal of pesticides. Material and Methods: A cross-sectional study was conducted among 387 farmers of Lucknow who fulfilled the inclusion criteria. A multistage random sampling was done to interview the farmers. A pretested structured questionnaire was to collect the information regarding the cognizance about use and risks of overuse of pesticides and evaluate practices for the storage, preparation, and disposal of pesticides. Results: More than half (55%) of the farmers did not read and follow the pesticide label. Maximum (80.2%) were unaware that pesticides are banned or restricted for use. Thirty-seven percent did not know that some pesticides may cause lethal intoxications. Majority of the farmers (42.6%) stored the pesticides anywhere in the house. More than two-thirds of the farmers (69.7%) mixed only needed pesticides followed by a low percentage of them applying on other crops (15.8%) and dispose in the field (11.7%). Conclusion: The study concludes that cognizance and practices of the farmers for pesticide use and risks associated with it was not satisfactory and exposes them to adverse health outcomes.
A BSTRACT Objectives: The aim of this study was to determine the adverse events following immunisation (AEFI) in various age groups after coronavirus disease 2019 (COVID-19) vaccination and assess the association of comorbidities with AEFI. Methods: An observational analytical study was conducted among the general population who had received both doses of the COVID-19 vaccine. A total of 389 participants from the 18–44 years age group, 380 participants from the 45–60 years age group and 373 participants from the 60 plus age group were enrolled in the study after verbal and written consent. Simple random sampling was used to select the study participant in each group. Home visits were made to fill out the semi-structured questionnaire for information regarding any adverse event following COVID-19 immunisation. Results: Overall, 31.9%, 19.74% and 15.17% of >60, 45–60 and 18–44 years, respectively, reported any AEFI after COVID-19 immunisation. The severity of AEFI was more among the 18–44 years age group (66.1%) followed by 45–60 years (30.67%) and less among the older one, that is, >60 years. Fever and pain with inflammation at the injection site were the most common AEFI reported after any dose. There was no association of comorbidity with the severity of AEFI. Conclusion: Since the AEFI reported are very less, most of them were of a minor type and were general immunogenic reactions of any vaccine. Hence the COVID-19 vaccines are very safe, and uptake should be high among all the recommended age groups to combat the severity of the COVID-19 disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.